Catalio Capital Management is a multi-strategy investment firm focused on breakthrough biomedical technology and innovative healthcare companies worldwide. The company was founded in 2020 by George Petrocheilos and R. Jacob Vogelstein to invest in the next generation of category-defining life sciences companies.